by pepidwpblog | Sep 14, 2018 | Press & Media
For Immediate Release: September 14, 2018 — Phoenix, AZ STATEMENT: PEPID, LLC, the leading provider of point-of-care medical information and clinical decision support, gives free access of PEPID’s Suites to first responders and clinicians within the emergency...
by PEPID Newsroom | Aug 17, 2018 | Alerts
The FDA has approved the first generic version of Mylan’s EpiPEN and EpiPen Jr (epinephrine) auto injector used to treat emergency allergic reactions, such as the life-threatening anaphylaxis. The generic epinephrine auto-injector has been green flagged to market in...
by Megan Pullins | Aug 16, 2018 | Primary Care
A recent study of adults who survived childhood cancer revealed increased exercise (with a mean of 7.9 Metabolic Equivalent Task) over eight years was associated with 40% reduction in all-cause mortality rate when compared to low maintenance of...
by PEPID Newsroom | Aug 16, 2018 | Alerts
The U.S. FDA approved the first of its kind targeted RNA-based therapy Onpattro (patisiran) to treat peripheral nerve disease (polyneuropathy) caused from hereditary transthyretin-mediated amyloidosis (hATTR) in adult patients. This is the first FDA approved treatment...
by PEPID Newsroom | Aug 13, 2018 | Emergency Medicine, Nursing, Pharmacy, Primary Care
Following the Centers for Medicare & Medicaid Services’ (CMS) April 2018 rule proposal announcement, comes the finalization of the “Promoting Interoperability” rule (PI, formerly known as the Meaningful Use program, or Medicare and Medicaid EHR Incentive Program)....
by PEPID Newsroom | Aug 3, 2018 | Emergency Medicine, Nursing, Pharmacy, Primary Care, Uncategorized
August kicks off with World Breastfeeding Week, now on its 27th year since it was first celebrated by the World Alliance for Breastfeeding Action (WABA) in 1992. Every August 1-7, WABA partners with a worldwide network of organizations to encourage breastfeeding,...
by Anna Tan | Aug 3, 2018 | Nursing, Pharmacy, Primary Care
On July 20, 2018, the U.S. Food and Drug Administration (FDA) approved the first acute myeloid leukemia treatment. It is the first approved targeted cancer therapy for patients with relapsed or refractory acute myeloid leukemia (R/R AML), specifically, those screened...
by PEPID Newsroom | Aug 1, 2018 | Emergency Medicine, Press & Media
Phoenix, AZ, USA, August 1, 2018 — Medical information and clinical solutions developer, PEPID, LLC, will attend the largest emergency medicine (EM) convention in the country. The annual American College of Emergency Physicians (ACEP) Scientific Assembly will take...
by Megan Pullins | Jul 16, 2018 | Emergency Medicine, Nursing, Pharmacy, Primary Care
Evidence that Adverse Drug Interactions Occur from Herbal-Drug Interactions and Non-Prescription Drug Interactions. “Natural” is widely perceived by the public to ensure safety. However, studies show drug interactions with active pharmaceutical agents, and...
by PEPID Newsroom | Jul 12, 2018 | Alerts
Tecovirimat (TPOXX) is the first FDA approved drug treatment of smallpox. In 1980, WHO declared that smallpox was eradicated; however, tecovirimat was developed as a counter to the possible use of smallpox as a bio-weapon. It is the first product awarded a Material...
